November 26, 2025

FDA Grants Accelerated Approval of Voyxact

The subcutaneous injection offers a new option for adults at risk of progression to kidney failure.

Conexiant

November 25, 2025

FDA Approves Reformulated Ranitidine

The reformulated heartburn medication comes with strict storage requirements

Conexiant

November 25, 2025

FDA OKs First SMA Gene Replacement Therapy

The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.

Conexiant

November 24, 2025

‘It Should Have Never Been Published’ Debate Continues

Experts counter Robert F. Kennedy Jr.’s claims about aluminum adjuvant safety, noting extensive evidence that aluminum-containing vaccines remain effective and well-validated.

KFF Health News

November 24, 2025

Why Youth E-Bike Injuries Are Increasing

Rising youth e-bike use and injuries amid limited federal oversight and evolving state safety rules.

KFF Health News

November 21, 2025

Which Antidepressants Shift Physiology?

Researchers found differences in how antidepressants affect weight, blood pressure, heart rate, and other physiological parameters.

Conexiant

November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 17, 2025

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

Conexiant

November 14, 2025

The Vaccine Shift No One Saw Coming

Conflicting policies, access hurdles, and misinformation are fueling a sharp drop in vaccinations that experts warn could deepen this season.

KFF Health News